|2000D-1350 - Draft Guidance for Industry on Labeling for Combined Oral Contraceptives; Availability|
|FDA Comment Number :||EC3|
|Submitter :||Dr. Daniel Grossman||Date & Time:||05/03/2004 06:05:07|
|Organization :||Population Council|
| I attempted to upload this comment earlier and received an error message, and this is a duplicate submission.
These comments are submitted on behalf of the Reproductive Health Program of the Population Council.
Daniel Grossman, M.D., F.A.C.O.G.,
One Dag Hammarskjold Plaza,
New York, NY 10017